Future Directions in the Management of Multiple Myeloma
Alfred L. Garfall, MD, discusses his hopes for the future treatment landscape of multiple myeloma.
ASCO 2024: DREAMM-8 Study of Belantamab Mafodotin, Pomalidomide, and Dexamethasone
Alfred L. Garfall, MD, discusses follow-up data from the DREAMM-8 study presented at ASCO 2024.
Use of Prophylactic Tocilizumab with Teclistamab: Takeaways from ASCO 2024
Alfred L. Garfall, MD, discusses long-term follow-up data from the MajesTEC-1 study presented at ASCO 2024.